Overview
Digital Health can be described as the convergence between digital technologies and healthcare solutions. However, multiple questions concerning both the usage and sharing of data and the pricing and reimbursement of digital health solutions remain unanswered.
By putting in the same table Industry representatives, involved in the multiple Digital Health related disciplines, together with Regulatory Agencies and other relevant stakeholders, this Workshop aims to be a discussion platform for the currently most relevant Digital Health topics, such as the qualification procedures across the globe, Real World insight generation, Data ethics, pricing and reimbursement of Digital Health solutions, virtual and remote trials, among many others. Join us to learn more on the fast evolving Digital Healthcare ecosystem and to listen to the aspiration from various stakeholders on the future of Digital health and the value to patients, HCP, Payers and many other players in healthcare.
Featured topics
- Early dialogue with regulators and qualification procedure across the globe
- Patient centricity as the key – the link between the biology of the disease and Digital Health solutions
- Real World insight generation
- Technology:
- Mobile health
- Sensors and endpoints
- Artificial Intelligence and Machine learning
- Aspirations towards the future of Digital Health
- Data ethics: access, usage, and sharing of data
- Pricing and reimbursement of Digital Health solutions
- Decentralized, virtual and Remote trials
Who should attend?
Professionals involved in:
- Digital health
- Digital solutions
- Data Management
- R&D
- Innovation
- Artificial Intelligence and Machine Learning
- Clinical operations and Clinical development
- Market Access & Reimbursement
- Bioethics
- Real World Evidence
- Regulatory Innovation
- Patient Advocacy
Learning objectives
- Recognise the current challenges and opportunities in Digital Health, both scientifically, in terms of value proposition and credibility of Data
- Discuss what is Digital Ethics and how to use it
- Understand the current regulatory thinking regarding new technologies
Program Committee
-
Katarzyna Kolasa, PhD • Professor of Health Economics, Head of Dept. of Health Economics and Health Mgmt
Kozminski University, Poland -
Maria Raad • Vice President, Customer and Digital Strategy
Janssen EMEA Commercial, Switzerland -
Michael Forstner, PhD • Head of Clinical and Patient Safety
Biogen BBU, Switzerland -
Scott Askin, MSc • Global Program Regulatory Director
Novartis Pharma AG, Switzerland
